nicotinic acids

Preferred Label : nicotinic acids;

MeSH definition : 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin.;

MeSH synonym : acids, nicotinic;

MeSH annotation : /defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther;

Wikipedia link : https://en.wikipedia.org/wiki/Nicotinic acids;

Codes EINECS : 200-441-0;

Is substance : O;

Détails

Origin ID

D009539;

UMLS CUI

C0028049;

ATC code(s)
- nicotinic acid and derivatives [ATC Code]
- nicotinic acid and derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Niacin [LOINC component]
- Niacin [ICD-11 Extension code]
- nicotinic acid [Substance BNPC]
False automatic mappings
- Adenine [FMA entity]
Pharmacological action(s)
- vitamin B complex [MeSH Descriptor]
Record concept(s)
- nicotinic acids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2,2'-bipyridine)-5,5'-dicarboxylic acid [MeSH Supplementary Concept]
- (2,2'-bipyridine)-5-carboxylic acid [MeSH Supplementary Concept]
- (phenylthio-4-phenylamino)-2-nicotinic acid [MeSH Supplementary Concept]
- 1,3-bis(4,6-dimethyl-1H-nicotinonitrile-1-yl)1,3-dioxy propane [MeSH Supplementary Concept]
- 1,4,5,6-tetrahydro-6-oxonicotinic acid [MeSH Supplementary Concept]
- 1,4-dihydrotrigonelline [MeSH Supplementary Concept]
- 1,6-dimethyl-4-hydroxy-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- 2,6-pyridine dimethanol dinicotinoate [MeSH Supplementary Concept]
- 2-((3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino)nicotinic acid [MeSH Supplementary Concept]
- 2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid [MeSH Supplementary Concept]
- 2-(2-chlorobenzylamino)-1-(2,3-dihydro-1H-inden-1-yl)-1H-imidazo(4,5-b)pyridine-5-carboxamide [MeSH Supplementary Concept]
- 2-(5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyloxy)ethyl nicotinate [MeSH Supplementary Concept]
- 2-amino-6-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-4-piperidin-4-yl nicotinonitrile [MeSH Supplementary Concept]
- 2-aminonicotinic acid [MeSH Supplementary Concept]
- 2-hydroxynicotinic acid [MeSH Supplementary Concept]
- 2-mercaptonicotinic acid [MeSH Supplementary Concept]
- 2-methyl-3-hydroxypyridine-5-carboxylic acid [MeSH Supplementary Concept]
- 2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxylate [MeSH Supplementary Concept]
- 2-trifluoromethyl-4-iodo-nicotinic acid [MeSH Supplementary Concept]
- 3-amino-5-chloro-6-methoxy-4-methyl-thieno(2,3-b)pyridine-2-carboxylic acid cyclopropylamide [MeSH Supplementary Concept]
- 3-carboxy-1-octylcarbamoylmethylpyridinium [MeSH Supplementary Concept]
- 3-methyl-5-phenylethyl 1,4-dihydro-2,6-dimethyl-4-(1-methyl-2-methylsulfonyl-5-imidazolyl)-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- 4-(2-(p-hydroxybenzoyl)vinyl)phenyl nicotinate [MeSH Supplementary Concept]
- 4-(4'-chlorobenzyloxy)benzyl nicotinate [MeSH Supplementary Concept]
- 4-hydroxy-2-methyl-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- 4-hydroxy-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- 4-oxo-1,4-dihydro-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- 5,6-dichloronicotinic acid [MeSH Supplementary Concept]
- 5-(2-fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate [MeSH Supplementary Concept]
- 5-aminonicotinic acid [MeSH Supplementary Concept]
- 5-bromo-2-methoxy-6-methylaminopyridine-3-carboxylic acid [MeSH Supplementary Concept]
- 5-bromonicotinic acid [MeSH Supplementary Concept]
- 5-chloro-2-hydroxynicotinic acid [MeSH Supplementary Concept]
- 5-fluoro-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- 5-hydroxynicotinic acid [MeSH Supplementary Concept]
- 5-methyl-1-nicotinoyl-2-pyrazoline [MeSH Supplementary Concept]
- 5-pyridoxic acid [MeSH Supplementary Concept]
- 6,6'-dithiodinicotinic acid [MeSH Supplementary Concept]
- 6-((2-(2-fluoro-6-(trifluoromethyl)phenoxy)-2-methylpropyl)carbamoyl)pyridine-3-carboxylic acid [MeSH Supplementary Concept]
- 6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid [MeSH Supplementary Concept]
- 6-(3,3-diphenylpropyl)guvacine [MeSH Supplementary Concept]
- 6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid [MeSH Supplementary Concept]
- 6-(5-(3-fluorobenzyloxy)-2-propoxybenzamido)nicotinic acid [MeSH Supplementary Concept]
- 6-chloronicotinic acid [MeSH Supplementary Concept]
- 6-fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester [MeSH Supplementary Concept]
- 6-hydrazinopyridine-3-carboxylic acid [MeSH Supplementary Concept]
- 6-hydroxynicotinic acid [MeSH Supplementary Concept]
- 6-mercapto-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- 6-mercaptonicotinic acid [MeSH Supplementary Concept]
- 7-ethyl-2-methyl-4-oxo-4,7-dihydrothieno(2,3-b)pyridine-5-carboxylic acid [MeSH Supplementary Concept]
- A 81988 [MeSH Supplementary Concept]
- AEC623892 [MeSH Supplementary Concept]
- AGN 190299 [MeSH Supplementary Concept]
- AMG 333 [MeSH Supplementary Concept]
- AO 1535 [MeSH Supplementary Concept]
- Dolo-Rubriment [MeSH Supplementary Concept]
- FG 5865 [MeSH Supplementary Concept]
- FG 5893 [MeSH Supplementary Concept]
- FG 5974 [MeSH Supplementary Concept]
- FR 144420 [MeSH Supplementary Concept]
- Fmoc-N-epsilon-(Hynic-Boc)-lysine [MeSH Supplementary Concept]
- GR 117289 [MeSH Supplementary Concept]
- HUM 5007 [MeSH Supplementary Concept]
- IPD-196 [MeSH Supplementary Concept]
- Inositol Niacinate [MeSH Supplementary Concept]
- KC 764 [MeSH Supplementary Concept]
- KR-62436 [MeSH Supplementary Concept]
- L 44-0 [MeSH Supplementary Concept]
- LG 100268 [MeSH Supplementary Concept]
- N'-(2-methyl-3-phenylallylidene)nicotinohydrazide [MeSH Supplementary Concept]
- N'-(3,5-dibromo-2-hydroxy-benzylidenene)nicotinic acid hydrazide [MeSH Supplementary Concept]
- N(1)-methyl-2-pyridone-5-carboxylic acid [MeSH Supplementary Concept]
- N,N'-bis(6-(N-3-dimethylaminopropyl)carbamoylpyridin-2-yl)pyridine-2,5-dicarboxamide [MeSH Supplementary Concept]
- N-glucopyranosylnicotinic acid [MeSH Supplementary Concept]
- N-methyl-5-hydroxynicotinic acid [MeSH Supplementary Concept]
- N-methylpyridine-2-carboxamide [MeSH Supplementary Concept]
- N-nicotinoyl tyramine [MeSH Supplementary Concept]
- N-phenyl-2-pyridinecarboxamide [MeSH Supplementary Concept]
- N-succinimidyl-5-iodo-3-pyridinecarboxylic acid [MeSH Supplementary Concept]
- NIP 101 [MeSH Supplementary Concept]
- Nico-Padutin [MeSH Supplementary Concept]
- OPC 13463 [MeSH Supplementary Concept]
- PAK 104P [MeSH Supplementary Concept]
- PN 202-791 [MeSH Supplementary Concept]
- RGPU-151 [MeSH Supplementary Concept]
- Ru-Vert [MeSH Supplementary Concept]
- S 50131 [MeSH Supplementary Concept]
- S 51434 [MeSH Supplementary Concept]
- SC 71952 [MeSH Supplementary Concept]
- SK&F 100330-A [MeSH Supplementary Concept]
- SQ 20006 [MeSH Supplementary Concept]
- SQ 20385 [MeSH Supplementary Concept]
- SQ 65442 [MeSH Supplementary Concept]
- U 56324 [MeSH Supplementary Concept]
- alpha-tocopheryl nicotinate [MeSH Supplementary Concept]
- azidobenzoylneonicotinoid [MeSH Supplementary Concept]
- azidoneonicotinoid [MeSH Supplementary Concept]
- bay T 5006 [MeSH Supplementary Concept]
- bayolin [MeSH Supplementary Concept]
- benzyl pyridine-3-carboxylate, camphor, capsici extract, diethylammonium salicylate, dolo visano, salicylamide drug combination. [MeSH Supplementary Concept]
- binifibrate [MeSH Supplementary Concept]
- butyl nicotinate [MeSH Supplementary Concept]
- celangulatin G [MeSH Supplementary Concept]
- celangulatin H [MeSH Supplementary Concept]
- celangulatin I [MeSH Supplementary Concept]
- chromium dinicotinate [MeSH Supplementary Concept]
- chromium nicotinic acid complex [MeSH Supplementary Concept]
- ciclonicate [MeSH Supplementary Concept]
- clofibrate, inositol nicotinate drug combination [MeSH Supplementary Concept]
- copper(I)-(nicotinic acid)(2) chloride complex [MeSH Supplementary Concept]
- dichlorotetrakis(3,5-pyridinedicarboxylic acid)ruthenium(II) [MeSH Supplementary Concept]
- dichlorotetrakis(nicotinic acid)ruthenium(II) [MeSH Supplementary Concept]
- diethyl 1,4-dihydro-2,6-dimethyl-4-(4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl)-3,5-pyridinedicarboxylate [MeSH Supplementary Concept]
- diethylaminosalicylate, heparin, nicotinic acid methyl ester drug combination [MeSH Supplementary Concept]
- diflufenzopyr [MeSH Supplementary Concept]
- digoxin, nicotinic acid, pentifylline drug combination [MeSH Supplementary Concept]
- dimethyl cathate [MeSH Supplementary Concept]
- diphenhydramine, meprobamate, nicotinic acid, pentaerythritol tetranitrate, drug combination [MeSH Supplementary Concept]
- dislipid [MeSH Supplementary Concept]
- dodecyl nicotinate [MeSH Supplementary Concept]
- dolo visano [MeSH Supplementary Concept]
- ethyl 6-aminonicotinate sulfonylurea [MeSH Supplementary Concept]
- ethylnicotinate [MeSH Supplementary Concept]
- exrheudon-salbe [MeSH Supplementary Concept]
- finalgon ointment [MeSH Supplementary Concept]
- flordipine [MeSH Supplementary Concept]
- gelimentum [MeSH Supplementary Concept]
- gerocerebrin [MeSH Supplementary Concept]
- glucitol hexanicotinate [MeSH Supplementary Concept]
- glucose tolerance factor [MeSH Supplementary Concept]
- guaiacyl-ortho-hydroxybenzoate nicotinate [MeSH Supplementary Concept]
- guvacine [MeSH Supplementary Concept]
- hexyl nicotinate [MeSH Supplementary Concept]
- hydrazinonicotinic acid [MeSH Supplementary Concept]
- hydroxynicotinic acid phosphate [MeSH Supplementary Concept]
- imazapic [MeSH Supplementary Concept]
- imazethapyr [MeSH Supplementary Concept]
- inositol nicotinate, mefruside, reserpine drug combination [MeSH Supplementary Concept]
- inositol nicotinate, pholedrine sulfate, troxerutin drug combination [MeSH Supplementary Concept]
- isonixin [MeSH Supplementary Concept]
- juston [MeSH Supplementary Concept]
- litonit [MeSH Supplementary Concept]
- magnesium chlorphenoxyisobutyrate, mesoinositol hexanicotinate drug combination [MeSH Supplementary Concept]
- meso-cinchomeronimide [MeSH Supplementary Concept]
- methyl 2-methoxy-6-methylaminopyridine-3-carboxylate [MeSH Supplementary Concept]
- methyl 6-aminonicotinate [MeSH Supplementary Concept]
- methyl nicotinate [MeSH Supplementary Concept]
- neopeviton [MeSH Supplementary Concept]
- niacytin [MeSH Supplementary Concept]
- niadenate [MeSH Supplementary Concept]
- nicametate [MeSH Supplementary Concept]
- nicoboxil [MeSH Supplementary Concept]
- nicodan [MeSH Supplementary Concept]
- nicomol [MeSH Supplementary Concept]
- nicomorphine [MeSH Supplementary Concept]
- nicophyllin [MeSH Supplementary Concept]
- nicospan [MeSH Supplementary Concept]
- nicotinanilide [MeSH Supplementary Concept]
- nicotinic acid N-alpha-arabinoside [MeSH Supplementary Concept]
- nicotinic acid benzyl ester [MeSH Supplementary Concept]
- nicotinic acid hydrazide [MeSH Supplementary Concept]
- nicotinic acid, pentifylline drug combination [MeSH Supplementary Concept]
- nicotinoyl methylcellulose [MeSH Supplementary Concept]
- nicotinoyl-N-oxysuccinimide [MeSH Supplementary Concept]
- nicotinuric acid [MeSH Supplementary Concept]
- nicotinyl 6-aminonicotinate [MeSH Supplementary Concept]
- nicotinyl tryptophanate [MeSH Supplementary Concept]
- nicotinyl tyrosinate [MeSH Supplementary Concept]
- nikogamol [MeSH Supplementary Concept]
- nooglutil [MeSH Supplementary Concept]
- norfloxacin nicotinate [MeSH Supplementary Concept]
- octotiamine [MeSH Supplementary Concept]
- octyl nicotinate [MeSH Supplementary Concept]
- oxythiamine disulfide nicotinate [MeSH Supplementary Concept]
- pepluanin A [MeSH Supplementary Concept]
- pernionin [MeSH Supplementary Concept]
- phenyl nicotinate [MeSH Supplementary Concept]
- poly(acrylic acid)-cysteine-2-mercaptonicotinic acid [MeSH Supplementary Concept]
- praecordin [MeSH Supplementary Concept]
- prevasore [MeSH Supplementary Concept]
- progresin (Retard) [MeSH Supplementary Concept]
- rheunervol [MeSH Supplementary Concept]
- ro 13-5478 [MeSH Supplementary Concept]
- ryanodyl 3-(pyridine-3-carboxylate) [MeSH Supplementary Concept]
- senilex [MeSH Supplementary Concept]
- sodium 6-((5-chloro-2-(((4-chloro-2-fluorophenyl)methyl)oxy)phenyl)methyl)-2-pyridinecarboxylate [MeSH Supplementary Concept]
- starch-nicotinate copolymer [MeSH Supplementary Concept]
- tazarotene [MeSH Supplementary Concept]
- tazarotenic acid [MeSH Supplementary Concept]
- thermosan [MeSH Supplementary Concept]
- thurfyl nicotinate [MeSH Supplementary Concept]
- triflocin [MeSH Supplementary Concept]
- vitamin A, pentifyllin, nicotinic acid, and vitamin E combination [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
- Vitamin [UMLS semantic type]
Validated automatic mappings to BTNT
- Niacin [NCIt concept]
- Nicotinic acid [SMS substance]
- Nicotinic acid (substance) [SNOMED CT concept]
- niacin [SNOMED Notion]
- nicotinic acid [ATC Code]
- nicotinic acid [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients